Abstract: This invention is directed generally to cefquinome compositions, processes for making such compositions, uses of such compositions to make medicaments, kits for making such compositions, and methods for using such compositions and kits to treat infections.

Abstract: The present invention relates to compositions of water dispersible and water soluble carbohydrate polymers and biologically active macromolecules of growth hormones, somatomedins, growth factors, and other biologically active fragments which are suitable for parenteral administration. The present invention also relates to a method for increasing and for maintaining increased levels of growth hormone in the blood of treated animals for extended periods of time, increasing weight gains in animals, and increasing milk production of lactating animals by the administration of the compositions of the invention.

Abstract: The present invention relates to compositions of water dispersible and water soluble carbohydrate polymers and biologically active macromolecules of growth hormones, somatomedins, growth factors, and other biologically active fragments which are suitable for parenteral administration. The present invention also relates to a method for increasing and for maintaining increased levels of growth hormone in the blood of treated animals for extended periods of time, increasing weight gains in animals, and increasing milk production of lactating animals by the administration of the compositions of the invention.

Abstract: The invention relates to compositions for the parenteral administration of an essentialy uniform and continuous amount of a phenylethanolamine derivative over an extended period of time. The invention also relates to the preparation and administration of said compositions.

Abstract: The invention relates to compositions for the parenteral administration of an essentially uniform and continuous amount of a peptide, which has a molecular weight of up to about 5,000, over an extended period of time. The peptide composition comprises a compacted and partially coated C.sub.10 -C.sub.20 fatty acid salt of the peptide. Examples of peptides useful in the invention includehis-D-trp-ala-trp-D-phe-lys-NH.sub.2,bradykinin, luteinizing hormone releasing hormone, growth releasing factor and poly-l-lysine. The invention also relates to the preparation and administration of said peptide compositions.

Abstract: The invention relates to compositions for the parenteral administration of an essentially uniform and continuous amount of a phenylethanolamine derivative over an extended period of time. The invention also relates to the preparation and administration of said compositions.

Abstract: The invention is a microsphere composition of fat or wax or mixture thereof and a biologically active protein, peptide or polypeptide suitable for parenteral administration. The invention is also a slow release composition of fat or wax or mixture thereof and a biologically active protein, peptide or polypeptide suitable for parenteral administration. The invention also relates to methods for increasing and maintaining increased levels of growth hormone in the blood of treated animals for extended periods of time, increasing weight gains in animals, and increasing milk production of lactating animals by the administration of compositions of the invention.

Abstract: A low temperature cure, two component coating composition having an improved balance between pot life and speed of cure is provided. The coating composition includes a crosslinkable, solvent borne, solution polymer containing certain activated ester groups, and a hemiaminal. Also provided is a crosslinked coating obtained by curing the composition. Additionally, there is provided a process for increasing the pot life of a low temperature cure coating composition. The process includes the step of forming a hemiaminal from a crosslinking agent preferably prior to mixing the crosslinking agent with the polymer.

Abstract: A low temperature, moisture cure coating composition is provided. The coating composition, which is shelf stable, includes a crosslinkable, solvent borne, solution polymer containing certain activated ester groups, and a ketimine. Also provided is a crosslinked coating obtained by curing the composition.

Abstract: Coating compositions comprising a polymer containing repeating units derived from alkyl acrylamidoglycolate alkyl ethers or acrylamidoglycoamide alkyl ethers and reactive functions selected from hydroxy, carboxy and/or amido groups provide crosslinking coating compositions which are low in toxicity and low in evolution of toxic volatile reaction products.

Abstract: The use of amine-terminated triazine resin as crosslinking agent in coating formulations containing activated carboxylic ester polymers provides improved coating properties.